Standout Papers

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-... 2015 2026 2018 2022 541
  1. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts (2016)
    Ellen Stelloo, Remi A. Nout et al. Clinical Cancer Research
  2. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative (2015)
    Ellen Stelloo, Tjalling Bosse et al. Modern Pathology

Immediate Impact

1 by Nobel laureates 4 from Science/Nature 66 standout
Sub-graph 1 of 18

Citing Papers

Succinate Nanomaterials Boost Tumor Immunotherapy via Activating Cell Pyroptosis and Enhancing MHC-I Expression
2025 Standout
Activatable Photosensitizers: From Fundamental Principles to Advanced Designs
2025 Standout
2 intermediate papers

Works of Ellen Stelloo being referenced

Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study
2017
Microsatellite instability derivedJAK1frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancer
2016

Author Peers

Author Last Decade Papers Cites
Ellen Stelloo 1607 1164 747 32 2.6k
Deborah F. DeLair 955 977 539 47 2.3k
Aline Talhouk 2391 1791 817 51 3.4k
Niki Boyd 1194 1291 604 12 2.5k
Lluís Catasús 919 850 677 51 2.6k
Matthew F. Kohler 931 916 517 56 2.5k
Michael S. Anglesio 1224 1778 720 69 3.5k
Pia Vahteristo 1380 1228 765 81 4.3k
Nataliya Melnyk 707 731 516 18 2.0k
Amanda Hummer 853 910 600 46 3.5k
Leah Prentice 530 1018 452 26 2.2k

All Works

Loading papers...

Rankless by CCL
2026